MCHX
MARCHEX INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 13 Marchex reported Q1 2026 revenue of $10.6M (down 7% YoY from $11.4M)…
- X Jul 31 Short interest falls 30.8% to 32.0K
- R Aug 12 Marchex reported Q2 2026 GAAP revenue of $11.0M (down 5.6% YoY from…
- X Aug 14 Short interest jumps 38.8% to 44.4K
- X Aug 31 Short interest falls 35.6% to 28.6K
- X Sep 15 Short interest jumps 131.9% to 66.3K
- E Sep 22 M&A: Marchex Expands Investor Relations Program, Engages Pondel…
- X Sep 30 Short interest falls 43.1% to 37.7K
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q1 2026: 1 added (0 new), 0 trimmed or exited.
- EstimatesRISING
Current-quarter EPS estimate $0.030 → $0.040 over 90 days. 1 up, 0 down in 30 days.
- TrendDOWNTREND
14% below its 50-day average.
Who's buying
13F· Q1 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $970.00 |
| UBS Group AG | ADD | $141.00 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | $69.00 |
| BNP PARIBAS FINANCIAL MARKETS | NEAR_EXIT | $4.00 |
| JPMORGAN CHASE & CO | TRIM | $93.00 |
| SIMPLEX TRADING, LLC | NEAR_EXIT | — |
| UBS Group AG | DOUBLED | $9.6K |
| GOLDMAN SACHS GROUP INC | TRIM | $87.1K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Dec 2021Price is below the lowest target. Median implies +217%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Dec 28, 2021 | Roth Capital MAINTAIN | Buy |
| Jan 28, 2019 | Roth Capital UPGRADE | Buy |
| Aug 10, 2016 | Roth Capital DOWNGRADE | Neutral |
| Dec 21, 2015 | Roth Capital INITIATE | Buy |
| Jun 30, 2015 | HC Wainwright & Co. DOWNGRADE | Equal-Weight |
| Sep 19, 2014 | BMO Capital DOWNGRADE | Market Perform |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 1, 2026 | ARENDS MICHAEL A Vice Chairman | AWARD | $17.2T |
| Jul 1, 2026 | HOROWITZ RUSSELL C Chairman | AWARD | $23.7T |
| Mar 20, 2026 | HARTLESS TROY President & Chief Rev Officer | EXERCISE | 87,500 sh |
| Mar 20, 2026 | Feeney Francis J Chief Operating Officer & CLO | EXERCISE | 62,500 sh |
| Mar 20, 2026 | Nagle Brian Chief Financial Officer | EXERCISE | 7,500 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.04 | $0.04–$0.04 | +33.3% | $16.2M |
| Next Q | $0.03 | $0.03–$0.03 | +50.0% | $15.6M |
| Current FY | $0.04 | $0.04–$0.04 | -20.0% | $53.5M |
| Next FY | $0.16 | $0.16–$0.16 | — | $69.4M |
Short side
FINRA· Oct 15, 2026SecBot reports
7 filings · 1 press release · 0 bullish · 0 bearish · 4 mixed · 3 neutral- NEUTRAL PRESS RELEASESep 22, 2026
Marchex has engaged PondelWilkinson, an investor relations firm, to support an expanded IR program…
Monitor future institutional ownership filings (13F) and any analyst coverage initiation as indicators of the IR program's effectiveness. No immediate stock-moving catalyst.
- MIXED 8-KAug 12, 2026
Marchex reported Q2 2026 GAAP revenue of $11.0M (down 5.6% YoY from $11.7M) and a GAAP net loss of…
The standalone Q2 miss is overshadowed by the Archenia acquisition closing and strong Q3 pro forma guidance. The key catalyst is the Q3 report in early November, which will be the first to include a…
- NEUTRAL DEFM14AJun 5, 2026
Marchex is seeking stockholder approval to acquire Archenia, a performance-based marketing tech…
Monitor the July 1 special meeting vote; approval is likely given Horowitz's voting control (75.5%), but the majority-of-minority condition requires separate approval from shares excluding insiders…
- MIXED PREM14AMay 26, 2026
Marchex is seeking stockholder approval for a related-party acquisition of Archenia, Inc., from…
The deal is a complex related-party acquisition that Marchex's own board acknowledges carries significant integration, customer retention, and overhang risk. The $10M note adds leverage to a company…
All MCHX filing & press-release reports (8)
- PRESS-RELEASE reportSep 22, 2026
- 8-K reportAug 12, 2026
- DEFM14A reportJun 5, 2026
- PREM14A reportMay 26, 2026
- DEFA14A reportMay 13, 2026
- 8-K reportMay 13, 2026
- 8-K reportMay 1, 2026
- 10-K/A reportApr 17, 2026